Original Research
Accepted on 28 Nov 2023
Evaluation of the humoral and mucosal immune response of a multiepitope vaccine against COVID-19 in pigs
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1276950
Type at least 3 characters
2,473 articles
Articles
Original Research
Accepted on 28 Nov 2023
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1264323
Original Research
Accepted on 28 Nov 2023
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1309997
Original Research
Accepted on 27 Nov 2023
Appropriate needle penetration depth for the intradeltoid muscle in vaccine administration among Thai populations
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1302891
Original Research
Accepted on 27 Nov 2023
Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1259386
Clinical Trial
Published on 27 Nov 2023
Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1292568
- 328 views
Review
Published on 27 Nov 2023
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1294288
- 578 views
Review
Published on 27 Nov 2023
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1277677
- 512 views
Review
Published on 27 Nov 2023
Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1294929
- 732 views
Review
Accepted on 24 Nov 2023
Integrated Control Strategies for Dengue, Zika, and Chikungunya virus infections
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1281667
Original Research
Accepted on 23 Nov 2023
Design of a Novel Multi-Epitopes Vaccine against Escherichia fergusonii: A Pan-proteome Based In-Silico Approach
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1332378
Original Research
Accepted on 23 Nov 2023
A COMMUNITY STUDY OF NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 IN CHINA
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1282612
Original Research
Accepted on 23 Nov 2023
Taming the SARS-CoV-2-mediated proinflammatory response with BromAc®
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1308477
Original Research
Accepted on 22 Nov 2023
Recombinant Antigen P29 of Echinococcus granulosus Induces Th1, Tc1, and Th17 Cell Immune Responses in Sheep
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1243204
Systematic Review
Published on 22 Nov 2023
Prevalence and genetic diversity of rotavirus in Bangladesh during pre-vaccination period, 1973-2023: a meta-analysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1289032
- 250 views
Original Research
Published on 21 Nov 2023
Enhancement of mucosal innate and adaptive immunity following intranasal immunization of mice with a bovine adenoviral vector
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1305937
- 245 views